Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R McDougall

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal of Endocrinological Investigation|April 21, 2001
Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?I R McDougall
Nuclear Medicine Communications|October 21, 1999
Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid carcinomaI R McDougall
Scottish Medical Journal|October 1, 1979
Diagnosis of abscesses by radionuclide scanningI R McDougall
Scottish Medical Journal|January 1, 1978
Liposomes and vesiclesI R McDougall
The Western Journal of Medicine|July 1, 1992
Radionuclide therapy for thyroid diseaseI R McDougall
Nuclear Medicine Communications|June 1, 1997
74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancerI R McDougall
Scottish Medical Journal|April 1, 1979
Stanford University Medical SchoolI R McDougall
Nuclear Medicine Communications|April 1, 1992
Letter from America (1991-92). AIDSI R McDougall
Nuclear Medicine Communications|July 15, 1999
Cancer deaths after 131I therapy for thyrotoxicosisI R McDougall
British Medical Journal|February 4, 1978
Arthritis simulating thrombosis on urokinase scanI R McDougall
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal of Endocrinological Investigation|April 21, 2001
Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?I R McDougall
Nuclear Medicine Communications|October 21, 1999
Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid carcinomaI R McDougall
Scottish Medical Journal|October 1, 1979
Diagnosis of abscesses by radionuclide scanningI R McDougall
Scottish Medical Journal|January 1, 1978
Liposomes and vesiclesI R McDougall
The Western Journal of Medicine|July 1, 1992
Radionuclide therapy for thyroid diseaseI R McDougall
Nuclear Medicine Communications|June 1, 1997
74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancerI R McDougall
Scottish Medical Journal|April 1, 1979
Stanford University Medical SchoolI R McDougall
Nuclear Medicine Communications|April 1, 1992
Letter from America (1991-92). AIDSI R McDougall
Nuclear Medicine Communications|July 15, 1999
Cancer deaths after 131I therapy for thyrotoxicosisI R McDougall
British Medical Journal|February 4, 1978
Arthritis simulating thrombosis on urokinase scanI R McDougall
Pageof 16